We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Altria, Coca-Cola, PepsiCo, Constellation and Canopy Growth
Read MoreHide Full Article
For Immediate Release
Chicago, IL –October 17, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Altria Group Inc. (MO - Free Report) , Coca-Cola Company (KO - Free Report) , PepsiCo (PEP - Free Report) , Constellation Brands (STZ - Free Report) and Canopy Growth Corp. (CGC - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Cannabis Market Attracts Cigarette Makers
Altria Group Inc., America’s leading cigarette manufacturer, is in talks with Canadian cannabis producer Aphria Inc. to buy a stake in it, The Globe & Mail reported last week.
Altria, parent of Marlboro cigarette-maker Philip Morris USA, is making the move at a time when Canada is set to legalize recreational marijuana on Oct 17.
This could be one of the reasons why many consumer goods’ manufacturers, food and beverage giants are trying to partner with Canadian cannabis growers in recent months.
Marijuana’s Benefits and Market Growth Opportunities Entice Cigarette Makers
The marijuana industry is expected to reach $146.4 billion by 2025 end, at a compound annual growth rate of 34.6%, according to Grand View Report. This could be prompting American cigarette manufacturers to seek an entry into the booming cannabis market.
The legalization of medical and recreational marijuana could offer unlimited options in terms of newly formulated products that could attract health-conscious consumers.
Smoking marijuana for medical purposes has been legal across 29 states in the United States since January while recreational marijuana is legal in 9 states.
Benefits of medical marijuana include curing and preventing eye diseases such as Glaucoma, controlling epileptic seizures, decreasing anxiety, easing pain induced by arthritis etc.
Marijuana-infused beverages and food products captured the attention of major American giants such as Coca-Cola Company and PepsiCo. Earlier this year, these two companies announced their interest in preparing cannabidiol-infused products. Cannabidiol (CBD) is a non-psychotropic drug found in the cannabis plant and its benefits include curing seizures, reducing inflammation, preventing cancer from spreading rapidly and decreasing pain.
Major Investments Promise Solid Growth Prospects
Marijuana stocks have witnessed an uptick in their prices since mid-August when Constellation Brands confirmed it plans to invest an additional $4 billion in Canada’s Canopy Growth Corp. The Corona beer maker had acquired a 9.9% stake in Canopy Growth in October 2017.
Not a month later, Coca-Cola expressed its interest to invest in Aurora Cannabis. This was followed by PepsiCo’s inclination toward making investments in the marijuana industry. While Coke and Pepsi could be eyeing new food and beverage products, Altria’s plans to formulate new consumables in place of its classic cigars remain to be seen.
The increasingly changing preferences of consumers and the legalization of cannabis across Canada and many states in the U.S. indicate solid growth prospects for the Marijuana-exposed stocks.
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Altria, Coca-Cola, PepsiCo, Constellation and Canopy Growth
For Immediate Release
Chicago, IL –October 17, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Altria Group Inc. (MO - Free Report) , Coca-Cola Company (KO - Free Report) , PepsiCo (PEP - Free Report) , Constellation Brands (STZ - Free Report) and Canopy Growth Corp. (CGC - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Cannabis Market Attracts Cigarette Makers
Altria Group Inc., America’s leading cigarette manufacturer, is in talks with Canadian cannabis producer Aphria Inc. to buy a stake in it, The Globe & Mail reported last week.
Altria, parent of Marlboro cigarette-maker Philip Morris USA, is making the move at a time when Canada is set to legalize recreational marijuana on Oct 17.
This could be one of the reasons why many consumer goods’ manufacturers, food and beverage giants are trying to partner with Canadian cannabis growers in recent months.
Marijuana’s Benefits and Market Growth Opportunities Entice Cigarette Makers
The marijuana industry is expected to reach $146.4 billion by 2025 end, at a compound annual growth rate of 34.6%, according to Grand View Report. This could be prompting American cigarette manufacturers to seek an entry into the booming cannabis market.
The legalization of medical and recreational marijuana could offer unlimited options in terms of newly formulated products that could attract health-conscious consumers.
Smoking marijuana for medical purposes has been legal across 29 states in the United States since January while recreational marijuana is legal in 9 states.
Benefits of medical marijuana include curing and preventing eye diseases such as Glaucoma, controlling epileptic seizures, decreasing anxiety, easing pain induced by arthritis etc.
Marijuana-infused beverages and food products captured the attention of major American giants such as Coca-Cola Company and PepsiCo. Earlier this year, these two companies announced their interest in preparing cannabidiol-infused products. Cannabidiol (CBD) is a non-psychotropic drug found in the cannabis plant and its benefits include curing seizures, reducing inflammation, preventing cancer from spreading rapidly and decreasing pain.
Major Investments Promise Solid Growth Prospects
Marijuana stocks have witnessed an uptick in their prices since mid-August when Constellation Brands confirmed it plans to invest an additional $4 billion in Canada’s Canopy Growth Corp. The Corona beer maker had acquired a 9.9% stake in Canopy Growth in October 2017.
Not a month later, Coca-Cola expressed its interest to invest in Aurora Cannabis. This was followed by PepsiCo’s inclination toward making investments in the marijuana industry. While Coke and Pepsi could be eyeing new food and beverage products, Altria’s plans to formulate new consumables in place of its classic cigars remain to be seen.
The increasingly changing preferences of consumers and the legalization of cannabis across Canada and many states in the U.S. indicate solid growth prospects for the Marijuana-exposed stocks.
You can seethe complete list of today’s Zacks #1 Rank stocks here.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.